Mubark Mohammed N Alabudahash

Mubark Mohammed N Alabudahash is a Doctor of Philosophy holder and active researcher at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde. His academic profile centers on biochemical and molecular approaches to cancer diagnostics, with specific emphasis on biosensing technologies for early disease detection and biomarker analysis.

His research program focuses on tumor antigen characterization, ultracentrifugation techniques, and the development of advanced biosensors for extracellular vesicle isolation. Key interests include ovarian cancer screening methodologies, liquid biopsy applications, and nanotechnology integration in diagnostic tools, aligning with UN Sustainable Development Goals for improved healthcare outcomes.

Recent publications reveal a concentrated research trajectory in oncology-focused biosensing, demonstrating expertise in translating molecular biology principles into clinical diagnostic frameworks. His work consistently bridges fundamental biochemistry with practical diagnostic solutions, particularly in non-invasive cancer detection through extracellular vesicle analysis and tumor antigen profiling.